Sort
51,593 grants matching “hepatitis”
Toward Safer Gene Therapy for Hemophilia A
$2,492,072Roland W. Herzog · Indiana University Indianapolis · P01 · FY2024 · HL
Translational Immunology Research and Accelerated [vaccine] Development (TRIAD)
$2,490,625Anne Searls De Groot · University Of Rhode Island · U19 · FY2012 · AI
Southern Liver Health Cohort
$2,489,960Cathrine Hoyo · North Carolina State University Raleigh · UH3 · FY2023 · CA
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$2,488,424Catherine C McGowan · Vanderbilt University · U01 · FY2013 · AI
Vanderbilt HIV Clinical Trials Unit
$2,487,433David W Haas · Vanderbilt University Medical Center · UM1 · FY2020 · AI
Biogenesis and Catabolism of Atherogenic Lipoproteins
$2,485,299M Mahmood Hussain · Nyu Long Island School Of Medicine · P01 · FY2023 · HL
Epidemiology and Natural History of Cancer-Associated Viruses
$2,483,980Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,480,863Shruti H Mehta · Johns Hopkins University · U01 · FY2022 · DA
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
$2,479,615Steven Foung · Stanford University · U19 · FY2023 · AI
General Clinical Research Center
$2,478,297Sheldon M Retchin · Virginia Commonwealth University · M01 · FY2007 · RR
Regulation of hepatic and systemic immune responses
$2,472,718Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS
$2,471,663Stanford University · P01 · FY2004 · CA
Pitt-Ohio State Clinical Trials Unit
$2,468,833John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2023 · AI
Biogenesis and Catabolism of Atherogenic Lipoproteins
$2,467,924M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2025 · HL
RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM
$2,467,065Immune Disease Institute, Inc. · U19 · FY2004 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$2,464,363Pablo Tebas · University Of Pennsylvania · UM1 · FY2020 · AI
IN VITRO ANTIVIRAL SCREENING PROGRAM-HEPATITIS C & B VIRUS
$2,459,894Michael Murray · · N01 · FY2007 · AI
Endocannabinoids And Energy Homeostasis
$2,457,470George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit
$2,456,647Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2014 · AI
Washington Metropolitan Women's Interagency HIV Study
$2,455,223Mary A Young · Georgetown University · U01 · FY2012 · AI
Triglycerides, Diabetes and Cardiovascular Disease
$2,453,240Karin E. Bornfeldt · University Of Washington · P01 · FY2024 · HL
TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES
$2,451,962Rockefeller University · P50 · FY2000 · DA
Durable Alteration of the Human Immune system after Infection or Immunotherapy
$2,446,152Raymond T Chung · Massachusetts General Hospital · U19 · FY2024 · AI
Xenobiotic receptors
$2,445,645Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)
$2,442,720Amita Gupta · Johns Hopkins University · UM1 · FY2025 · AI